Singapore Proposes Class C Listing for Nitazenes; Offenders Could Face Jail Time

Jul.21.2025
Singapore Proposes Class C Listing for Nitazenes; Offenders Could Face Jail Time
Singapore’s Ministry of Health plans to classify nitazenes, a sedative found in one-third of tested e-cigarettes, as a Class C controlled substance under the Misuse of Drugs Act. The move follows reports of related fatalities. Once enforced, offenders could face mandatory rehabilitation and imprisonment, similar to penalties for hard drugs.

Key Points:

 

·Control upgrade: Singapore's Ministry of Health announced that the anesthetic propofol found in e-cigarettes will be classified as a Class C controlled substance under the Misuse of Drugs Act. 

 

·Hazard data: 33% of e-cigarettes tested contain this substance, and it has been linked to multiple cases of non-natural deaths. 

 

·Punitive measures: First-time offenders will be required to undergo compulsory rehabilitation treatment and be supervised in drug rehabilitation centers. Repeat offenders face a minimum of 1 year in prison. 

 

·Interdepartmental action: The Central Narcotics Bureau, the Environmental Protection Agency, and more than 10 other agencies are collaborating in enforcement efforts, with a focus on monitoring campuses as key areas for prevention and control.

 


【2Firsts News Flash】According to My News on July 20th, Singapore's Health Minister Ong Ye Kung announced on July 20th that the government is planning to classify the anesthetic propofol found in e-cigarettes as a Class C controlled substance under the Misuse of Drugs Act.

 

“The number of e-cigarettes containing ethyl methyl carbonate is increasing, which has sparked high concern from various agencies including the Ministry of Internal Affairs and the Ministry of Health.”

 

He expressed.

 

Authorities recently conducted random tests on over 100 e-cigarettes that were confiscated, and found that one third of them contained ethyl maltol.

 

Wang Yikang also pointed out that there have been some deaths related to the use of Mifepristone, including traffic accidents and unnatural death incidents. Investigations are still ongoing.

 

In Singapore, e-cigarettes are banned and regulated under the Tobacco (Control of Advertisements and Sale) Act. Nicotine, which is found in e-cigarettes, is currently a controlled substance under the Poisons Act.

 

“According to current laws, individuals using drug-laced pods may face fines, but these penalties will change when mitzethaine is included in the ‘Drug Abuse Act’.”

 

According to the bill, they will be treated equally with hard drug users such as marijuana or cocaine.

 

Wang Yikang stated.

 

This means they will be supervised, required to undergo mandatory rehabilitation treatment, and may be sent to a detox center. Repeat offenders will be prosecuted and may face at least one year of imprisonment.

 

We will take a few weeks to complete this process," the Minister of Health said, adding that listing mifepristone as a controlled substance is a "temporary measure".

 

Wang Yikang pointed out that although e-cigarettes were originally designed as a nicotine delivery device, they have now become a means of delivering a variety of substances from nicotine to psychoactive drugs such as methamphetamine and even hard drugs.

 

“In the face of this situation, it is necessary for various government agencies to come together and work collaboratively to combat it.”

 

Wang Yikang said. He added that in addition to the police and the Health Science Bureau, multiple agencies such as the National Park Administration, the National Environmental Protection Bureau, and the Road Traffic Administration have also been involved in the regulation of e-cigarettes.

 

“When e-cigarettes are seized, they will be handed over to the Department of Health for testing. If they only contain nicotine, we will handle it and impose fines. If there are more serious substances involved, other agencies will intervene. In the most severe drug-related cases, the Central Narcotics Bureau will be called in to investigate, so cooperation is needed.”

 

The Minister said.

 

Wang Yikang has warned that ingesting acetorphine through e-cigarettes could pose significant dangers, potentially leading to permanent organ damage and hallucinations.

 

When asked about the campus situation, Wang Yikang said:

 

“In a previous test, we tested e-cigarettes confiscated from schools and found no evidence of diacetyl. However, that was several months ago. In a recent random test of e-cigarettes confiscated from the public, one-third contained diacetyl, so I cannot assume that diacetyl has not made its way into schools.”

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's government unveiled its first Tobacco Harm Management Basic Plan for 2027–2031 on October 29, 2026, proposing broader testing of vaping and heated tobacco products while excluding nicotine analogs such as 6-methyl nicotine. Synthetic nicotine came under tobacco regulation on April 24, and a June investigation found 6-methyl nicotine in 12 liquid inhalation products marketed as nicotine-free. Customs data released in September showed that imports of nicotine analog solutions fell 83.3%, from 12 metric tons in January–April to 2 metric tons in May–August. By September 20, imports had reached approximately 15 metric tons for the year, with 99.99% originating from China. Customs authorities have tightened pre-clearance testing and supply-chain documentation requirements, while the MFDS expects to complete its assessment of nicotine analog hazards by the end of 2026.
Regulations
Nov.04
UK Extends Age-18 Rules to Zero-Nicotine Vapes and Nicotine Pouches From Oct. 29, Bans Vending Machines and Promotional Giveaways
UK Extends Age-18 Rules to Zero-Nicotine Vapes and Nicotine Pouches From Oct. 29, Bans Vending Machines and Promotional Giveaways
Key provisions of the UK's Tobacco and Vapes Act 2026 will take effect on Oct. 29, extending an age-18 sales restriction to all vaping and non-medicinal nicotine products. In England, Wales and Northern Ireland, the change brings zero-nicotine vapes within statutory age-of-sale rules and also covers products including nicotine pouches, strips and pearls. The law will also prohibit proxy purchasing for under-18s, consumer-facing vending machines, promotional giveaways and substantial discounts intended to promote vaping and nicotine products.
Regulations
Oct.10
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Imperial Brands' acquisition of Swedish Helwit owner Yoik Group AB has highlighted the professional-services firms supporting cross-border oral nicotine M&A. Latham & Watkins and KPMG advised Imperial, while PwC and TM & Partners advised Yoik. KPMG also appeared on Imperial's acquisition of Black Buffalo earlier in 2026, while PwC played an extensive role in KT&G's acquisition of Swedish nicotine-pouch company Another Snus Factory. Imperial's public disclosures put the global modern oral nicotine delivery market at approximately £8.8 billion in retail sales and 23.5 billion pouches in 2024
Sep.20